Validity and reliability of a novel, non-invasive tool and method to measure intra-abdominal pressure in vivo.

J Biomech

McGill University, Department of Mechanical Engineering, 845 Sherbrooke St. W, Montreal, Quebec, Canada, H3A 0G4. Electronic address:

Published: May 2022

Intra-abdominal hypertension has been recorded in between 20 and 50% of intensive care unit patients, with rates increasing in ventilated patients. This increased intra-abdominal pressure (IAP) can reduce blood flow to vital organs, perpetuating further pressure build-up as organs become unable to drain excess fluids. Measurement of IAP for the diagnosis of intra-abdominal hypertension remains highly invasive, thus, a non-invasive alternative to traditional IAP measurement was developed and validated, herein. Fourteen living participants and 13 cadaveric specimen were tested with this novel device for IAP measurement. Living participant results were compared to published IAP averages, while cadavers were tested against the existing gold standard: intra-vesical pressure (IVP). Intra- and inter-rater reliability in both living and cadaveric tests presented excellent results. Convergent validity against published IAP values was also excellent (in living participants) and moderate (in cadavers), while convergent validity against IVP was inconclusive. These promising results support the interest in further research, particularly with IVP comparisons in living participants.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbiomech.2022.111096DOI Listing

Publication Analysis

Top Keywords

living participants
12
intra-abdominal pressure
8
intra-abdominal hypertension
8
iap measurement
8
published iap
8
convergent validity
8
iap
6
living
5
validity reliability
4
reliability novel
4

Similar Publications

Importance: Apolipoprotein B (apoB) distribution and its implications as an atherosclerotic cardiovascular disease (ASCVD) risk-enhancing factor among individuals of diverse Hispanic or Latino backgrounds have not been described.

Objective: To describe the distribution of apoB in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) cohort and to characterize associations of baseline sociodemographic and clinical variables with apoB and self-identified Hispanic or Latino background.

Design, Setting, And Participants: The HCHS/SOL was a prospective, population-based cohort study of diverse Hispanic or Latino adults living in the US who were recruited and screened between March 2008 and June 2011.

View Article and Find Full Text PDF

Importance: Cutaneous chronic graft-vs-host disease (GVHD) is independently associated with morbidity and mortality after allogeneic hematopoietic cell transplant. However, the health-related quality-of-life (HRQOL) domains that are most important to patients are poorly understood.

Objective: To perform a concept elicitation study to define HRQOL in cutaneous chronic GVHD from the patient perspective and to compare experiences of patients with epidermal vs sclerotic disease.

View Article and Find Full Text PDF

Background: Pre-exposure prophylaxis for HIV prevention (PrEP) prescriptions in the U.S. have increased, yet only 15% of individuals assigned female at birth who could benefit from PrEP had received prescriptions as of 2022, with marked racial disparities.

View Article and Find Full Text PDF

Objective: Corpus callosum (CC) damage is the most consistent and typical change in early Parkinson's disease (PD), and is associated with various PD symptoms. However, the precise relationship between CC subregions and specific PD symptoms have not been identified comprehensively. In this study, we investigated the association between specific CC subregion alterations and PD symptoms using diffusion-weighted imaging.

View Article and Find Full Text PDF

Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 Trials.

J Am Coll Cardiol

November 2024

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

Background: Hypertension is common in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), and current guidelines recommend treating systolic blood pressure (SBP) to a target <130 mm Hg. However, data supporting treatment to this target are limited. Additionally, pulse pressure (PP), a marker of aortic stiffness, has been associated with increased risk of cardiovascular events, but its prognostic impact in HFpEF has not been extensively studied.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!